28 Oct 2021

‘Thank you for asking’: patient-centred research helps drive change in lung disease treatment

Physiotherapist monitoring and providing guidance for at home patients.
Image: Dr Narelle Cox. See also Narelle describing the research:
video

Monash University researchers are giving new hope to people with chronic obstructive pulmonary disease (COPD), with the COVID-19 pandemic prompting some of the first innovations in treatment models in 30 years.

See more:

Monash researchers bond with donors to fight rare cancers

Suzanne Neate (right) with her mother Teresa, who died in 2016.

by Anne Crawford

After Suzanne Neate’s mother Teresa died of thyroid cancer five years ago, Suzanne wanted to make an impact on the lives of other people similarly enduring high mortality rate cancers.

Teresa had spent time in rehabilitation; Suzanne thought of funding equipment, walkers or wheelchairs for those in care. “Then I thought ‘No, the problem is she shouldn’t have been there to begin with – how do you stop someone being there to begin with?’,” she said. “You research – everything comes back to research.”

Suzanne, CEO of The Aftershock, the not-for-profit organisation she founded in 2017, has joined forces on a research project into lethal oesophageal cancer with Professor Wendy Brown, Alfred Hospital surgeon, researcher and Head of Monash University’s Department of Surgery.

26 Oct 2021

Can delirium after major surgery be reduced by tranexamic acid?

ANZCA funded study will look at whether tranexamic acid can
reduce confusion and delirium after major surgery.
Congratulations to Professor Paul Myles on his grant from the Australia and New Zealand College of Anaesthetists (ANZCA) of $120,000 over two years for the project "Tranexamic acid to reduce delirium after gastrointestinal surgery: the TRIGS-D trial".

Delirium is a devastating complication of medical and surgical care, associated with increased morbidity and mortality, dementia and impaired long-term cognition, and loss of independence. 

How a very simple test can help clinicians see subtle cognitive changes in multiple sclerosis

L-R: Dr Daniel Merlo , Prof Helmut Butzkueven and A/Prof Anneke
Van Der Walt
are first and senior authors on a paper describing a tool
they have developed for assessing cognitive function in MS.
More than 50% of people living with multiple sclerosis (MS) experience cognitive problems as part of their disease. These cognitive problems subtly worsen with time and can be difficult to measure with standard neuropsychological assessments. Hence, it can be challenging for neurologists to monitor and detect small changes in cognitive function in day-to-day practice.

Monash researchers have developed a simple set of tests to detect subtle changes in cognitive function in people living with relapsing remitting multiple sclerosis (RRMS). The tests are collectively known as ‘MSReactor’.

25 Oct 2021

FightMND grant for detection of waste build-up in the brain

A/Prof David Wright using Monash's preclinical MRI scanner
at the Alfred site

Congratulations to Associate Professor David Wright on his FightMND grant, "The Glymphatic System: A novel biomarker of disease severity in MND". The project will receive $249,502 over a two year period.

Motor Neurone Disease (MND) affects around 1 in 300 people. It has a rapid progression: one third of people with MND die within a year of diagnosis, and over half die within two years.

19-25 Oct 2021 Central Clinical School recent publications

HCV & HIV co-infection treatment by
 nonspecialists is effective: Doyle et al
Image: Hepmag.com
Recent publications featuring research as notified by PubMed during 19-25 Oct 2021 from Central Clinical School affiliated researchers in the following departments. The below is not a comprehensive list. The most recent validated publications for the school and departments can be seen on their publications pages, linked to from the headings below. Otherwise, read down the entry for recent notifications.

Congratulations to Dr Matt Snelson on ECR symposium prize!

Congratulations to Dr Matthew Snelson, who in addition to his Alfred Health Week win of the Baker Heart and Diabetes Institute Prize for diabetes research has won the Monash Faculty of Medicine, Nursing and Health Sciences (FMNHS) Early Career Researcher Symposium Rapid Fire Presentation.

The FMNHS ECR Symposium brought together researchers from across the faculty with the theme of Reconnect and Turbocharge Your Career. A number of presentation awards were given, including the Rapid Fire Presentation Prize which was won by Dr Snelson for his presentation "Thermally processed diet-induced albuminuria, complement activation and intestinal permeability are attenuated by resistant starch in experimental diabetes".

Related Posts Plugin for WordPress, Blogger...